1. Proteomic Profiling of the Dystrophin-DeficientmdxPhenocopy of Dystrophinopathy-Associated Cardiomyopathy
    Ashling Holland et al, 2014, BioMed Research International CrossRef
  2. New pathobiochemical insights into dystrophinopathy from the proteomics of senescent mdx mouse muscle
    Ashling Holland et al, 2014, Front. Aging Neurosci. CrossRef
  3. Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy
    Thomas Fröhlich et al, 2016, Sci Rep CrossRef
  4. Label-free mass spectrometric analysis of themdx-4cvdiaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis
    Ashling Holland et al, 2015, Proteomics CrossRef
  5. Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds
    Tania Gamberi et al, 2018, Journal of Proteomics CrossRef
  6. Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin
    Sandra Murphy et al, 2017, J Muscle Res Cell Motil CrossRef
  7. Application of Fluorescence Two-Dimensional Difference In-Gel Electrophoresis as a Proteomic Biomarker Discovery Tool in Muscular Dystrophy Research
    Steven Carberry et al, 2013, Biology CrossRef
  8. Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy
    Sandra Murphy et al, 2015, Biology CrossRef
  9. Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers
    Ashling Holland et al, 2015, Molecules CrossRef
  10. Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles
    Sandra Murphy et al, 2015, Proteomes CrossRef
  11. Modulation of Protein Quality Control and Proteasome to Autophagy Switch in Immortalized Myoblasts from Duchenne Muscular Dystrophy Patients
    , 2018, IJMS CrossRef
  12. Proteomic profiling of liver tissue from the mdx-4cv mouse model of Duchenne muscular dystrophy
    Sandra Murphy et al, 2018, Clin Proteom CrossRef
  13. Comparative proteomic analysis of the contractile-protein-depleted fraction from normal versus dystrophic skeletal muscle
    Steven Carberry et al, 2014, Analytical Biochemistry CrossRef
  14. Emerging proteomic biomarkers of X-linked muscular dystrophy
    Paul Dowling et al, 2019, Expert Review of Molecular Diagnostics CrossRef
  15. Properties of regenerated mouse extensor digitorum longus muscle following notexin injury
    S. I. Head et al, 2014, Experimental Physiology CrossRef
  16. Chaperoning heat shock proteins: Proteomic analysis and relevance for normal and dystrophin-deficient muscle
    Heinrich Brinkmeier et al, 2014, Prot. Clin. Appl. CrossRef
  17. Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients
    Yetrib Hathout et al, 2014 CrossRef
  18. Biochemical and morphological alterations in the Achilles tendon ofmdxmice
    Andrea Aparecida De Aro et al, 2015, Microsc. Res. Tech. CrossRef
  19. Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle
    Martin Steinberger et al, 2015, Pflugers Arch - Eur J Physiol CrossRef
  20. Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis
    Ashling Holland et al, 2016, Proteomics CrossRef
  21. Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology
    Cara A. Timpani et al, 2015, Medical Hypotheses CrossRef
  22. Uncovering the exercise-related proteome signature in skeletal muscle
    Ana Isabel Padrão et al, 2016, Proteomics CrossRef
  23. Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation
    Heidi R. Fuller et al, 2016, Expert Review of Proteomics CrossRef
  24. Reduction in mdx mouse muscle degeneration by low-intensity endurance exercise: a proteomic analysis in quadriceps muscle of exercised compared with sedentary mdx mice
    Simona Fontana et al, 2015 CrossRef
  25. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy
    Cara A. Timpani et al, 2020, Sci Rep CrossRef
  26. Identification of marker proteins of muscular dystrophy in the urine proteome from the mdx-4cv model of dystrophinopathy
    Stephen Gargan et al, 2020, Mol. Omics CrossRef
  27. Dystrophin Dp71 Subisoforms Localize to the Mitochondria of Human Cells
    Emma Tabe Eko Niba et al, 2021, Life CrossRef
  28. Proteomic profiling of impaired excitation–contraction coupling and abnormal calcium handling in muscular dystrophy
    Paul Dowling et al, 2022, Proteomics CrossRef
  29. Early Developmental Changes of Muscle Acetylcholine Receptors Are Little Influenced by Dystrophin Absence in mdx Mouse
    Marta Morotti et al, 2022, Life CrossRef
  30. Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways
    Jackie L. McCourt et al, 2023, Skeletal Muscle CrossRef
  31. Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment
    Kalina Andrysiak et al, 2023 CrossRef
  32. Role of microenvironment on muscle stem cell function in health, adaptation, and disease
    Daniel Helzer et al, 2024 CrossRef
  33. Diapocynin treatment induces functional and structural improvements in an advanced disease state in the mdx mice
    Ghali Guedira et al, 2024, Biomedicine & Pharmacotherapy CrossRef